Skip to main content

Market Overview

32 Stocks Moving in Tuesday's Pre-Market Session

Share:
32 Stocks Moving in Tuesday's Pre-Market Session

Gainers

  • Novus Therapeutics, Inc. (NASDAQ: NVUS) rose 158.3% to $0.9790 in pre-market trading after the company reported the purchase of Anelixis Therapeutics.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 60.2% to $3.38 in pre-market trading after the company announced Ganaxolone achieved its primary endpoint in Phase 3 trial for CDKL5 deficiency disorder and was generally well-tolerated.
  • Lonestar Resources US Inc. (NASDAQ: LONE) rose 38% to $0.37 in pre-market trading after the company announced a restructuring support agreement to eliminate $390 million in debt obligation and preferred equity interests.
  • Town Sports International Holdings, Inc. (NASDAQ: CLUB) rose 23.4% to $0.3948 in pre-market trading after the company filed voluntary petitions for relief under Chapter 11 bankruptcy.
  • ARCA biopharma, Inc. (NASDAQ: ABIO) shares rose 17.4% to $5.61 in pre-market trading after gaining over 5% on Monday. ARCA biopharma, last month, posted a loss for its second quarter.
  • Sunworks, Inc. (NASDAQ: SUNW) rose 13.8% to $0.87 in pre-market trading after gaining around 11% on Monday.
  • América Móvil, S.A.B. de C.V. (NYSE: AMX) rose 9.9% to $14.83 in pre-market trading after gaining around 8% on Monday. Verizon announced plans to acquire America Movil’s Tracfone for up to $6.9 billion.
  • Immuron Limited (NASDAQ: IMRN) rose 9.3% to $8.62 in pre-market trading.
  • Harmony Gold Mining Company Limited (NYSE: HMY) rose 8.8% to $6.73 in pre-market trading.
  • Fiat Chrysler Automobiles N.V. (NYSE: FCAU) rose 8.7% to $12.97 in pre-market trading after the company announced it has agreed to amend certain terms of its binding 50/50 combination agreement with Peugeot S.A. to create Stellantis.
  • Lipocine Inc. (NASDAQ: LPCN) rose 8.4% to $1.44 in pre-market trading after climbing around 10% on Monday. The FDA, last month, informed the company that it needs additional time to complete its review of TLANDO's new drug application.
  • Cellectar Biosciences, Inc. (NASDAQ: CLRB) rose 8.3% to $1.30 in pre-market trading. Cellectar recently reported data on CLR 131 Phase 2 CLOVER-1 study in triple class refractory multiple myeloma patients.
  • Cars.com Inc. (NYSE: CARS) rose 8.1% to $9.24 in pre-market trading after gaining over 6% on Monday.
  • Future FinTech Group Inc. (NASDAQ: FTFT) rose 7.7% to $2.38 in pre-market trading after the company signed an equity acquisition frame agreement with Benma (Shenzhen) Industrial Co.
  • Seattle Genetics, Inc. (NASDAQ: SGEN) rose 7.1% to $184.00 in pre-market trading. SVB Leerink maintained Seattle Genetics with an Outperform and raised the price target from $173 to $185. Seattle Genetics shares climbed 15% on Monday after the company announced it would collaborate with pharmaceutical giant Merck on two Oncology drugs and that Merck would invest $1 billion in the company.
  • Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) rose 7% to $0.4598 in pre-market trading. Seanergy Maritime, last week, announced open-market stock purchase plan by the CEO of 500,000 common shares.
  • Camping World Holdings, Inc. (NYSE: CWH) rose 6.7% to $38.54 in pre-market trading after the company raised its FY21 EBITDA guidance.
  • Murphy Oil Corporation (NYSE: MUR) rose 6.5% to $10.86 in pre-market trading. MKM Partners, on Monday, upgrades Murphy Oil to Buy.
  • NextEra Energy Inc (NYSE: NEE) rose 6.5% to $300.10 in pre-market trading after the company raised its guidance for 2021 and 2022 and extended its longer-term growth forecast to 2023. The company’s board also approved a four-for-one stock split.
  • Ideanomics, Inc. (NASDAQ: IDEX) rose 5.7% to $1.28 in pre-market trading after surging 11% on Monday.
  • Vivint Solar, Inc. (NYSE: VSLR) rose 5% to $34.00 in pre-market trading after gaining over 6% on Monday.
  • Tesla, Inc. (NASDAQ: TSLA) shares rose 4% to $436.20 in pre-market trading in anticipation of the company's Battery day event next week. Additionally, the company reported an increase in car registrations for the month of August compared to July.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Qurate Retail, Inc. (NASDAQ: QRTEA) fell 37% to $6.89 in pre-market trading. Qurate Retail reported upbeat quarterly results last month.
  • Kraton Corporation (NYSE: KRA) fell 8.8% to $16.06 in pre-market trading.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares fell 6.6% to $7.24 in pre-market trading. Cassava Sciences shares surged 133% on Monday after the company announced results for a Phase 2b clinical study of Sumifilam in patients with Alzheimer's disease showed statistically significant improvements in biomarkers compared to placebo.
  • Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) fell 6.4% to $0.4401 in pre-market trading after dropping around 17% on Monday. Hancock Jaffe, last month, announced one year follow-up data on two additional VenoValve patients.
  • Humana Inc. (NYSE: HUM) shares fell 6.4% to $377.90 in pre-market trading after rising over 3% on Monday.
  • Nikola Corporation (NASDAQ: NKLA) fell 6% to $33.67 in pre-market trading. After Monday's closing bell, Bloomberg reported the U.S. Securities and Exchange Commission is examining Nikola"to assess the merits of a short-seller's allegations that the electric-truck maker deceived investors about its business prospects, according to people familiar with the matter."
  • Forterra Inc (NASDAQ: FRTA) fell 5.1% to $16.50 in pre-market trading after the company announced secondary offering of 10 million shares. Forterra also reported voluntary prepayment of term loan.
  • Vaxart, Inc. (NASDAQ: VXRT) shares fell 5.1% to $7.38 in pre-market trading after jumping around 47% on Monday. Vaxart recently announced its oral COVID-19 vaccine candidate induces potent systemic and mucosal immune response in preclinical studies.
  • PPD Inc (NASDAQ: PPD) shares fell 4.6% to $32.26 in pre-market trading after the company announced a 38 million share secondary common stock offering.
  • Miragen Therapeutics Inc (NASDAQ: MGEN) fell 3.2% to $0.91 in pre-market trading after the company reported the resignation of its President and CEO, William Marshall. miRagen also announced plans to review strategic alternatives.
 

Related Articles (ABIO + AMX)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com